{Reference Type}: Journal Article
{Title}: Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases.
{Author}: Chen T;Dai Y;Hu C;Lin Z;Wang S;Yang J;Zeng L;Li S;Li W;
{Journal}: Fluids Barriers CNS
{Volume}: 21
{Issue}: 1
{Year}: 2024 Jul 19
{Factor}: 6.961
{DOI}: 10.1186/s12987-024-00557-1
{Abstract}: BACKGROUND: Maintaining the structural and functional integrity of the blood-brain barrierĀ (BBB) is vital for neuronal equilibrium and optimal brain function. Disruptions to BBB performance are implicated in the pathology of neurodegenerative diseases.
METHODS: Early indicators of multiple neurodegenerative disorders in humans and animal models include impaired BBB stability, regional cerebral blood flow shortfalls, and vascular inflammation associated with BBB dysfunction. Understanding the cellular and molecular mechanisms of BBB dysfunction in brain disorders is crucial for elucidating the sustenance of neural computations under pathological conditions and for developing treatments for these diseases. This paper initially explores the cellular and molecular definition of the BBB, along with the signaling pathways regulating BBB stability, cerebral blood flow, and vascular inflammation. Subsequently, we review current insights into BBB dynamics in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. The paper concludes by proposing a unified mechanism whereby BBB dysfunction contributes to neurodegenerative disorders, highlights potential BBB-focused therapeutic strategies and targets, and outlines lessons learned and future research directions.
CONCLUSIONS: BBB breakdown significantly impacts the development and progression of neurodegenerative diseases, and unraveling the cellular and molecular mechanisms underlying BBB dysfunction is vital to elucidate how neural computations are sustained under pathological conditions and to devise therapeutic approaches.